MICHELI, VALERIA
 Distribuzione geografica
Continente #
NA - Nord America 2.362
AS - Asia 2.057
EU - Europa 1.995
Continente sconosciuto - Info sul continente non disponibili 196
SA - Sud America 190
AF - Africa 89
OC - Oceania 12
Totale 6.901
Nazione #
US - Stati Uniti d'America 2.262
IT - Italia 577
CN - Cina 572
SG - Singapore 560
DE - Germania 453
GB - Regno Unito 316
BD - Bangladesh 237
HK - Hong Kong 211
VN - Vietnam 167
RU - Federazione Russa 150
BR - Brasile 135
SE - Svezia 101
FR - Francia 97
IN - India 90
ID - Indonesia 78
CA - Canada 68
NL - Olanda 67
FI - Finlandia 53
IE - Irlanda 47
CI - Costa d'Avorio 38
KR - Corea 27
DK - Danimarca 23
TR - Turchia 20
UA - Ucraina 20
AR - Argentina 19
JP - Giappone 19
CH - Svizzera 15
AU - Australia 12
CO - Colombia 12
ZA - Sudafrica 12
BE - Belgio 11
PH - Filippine 11
ES - Italia 9
PL - Polonia 9
AT - Austria 8
MX - Messico 8
RO - Romania 8
SA - Arabia Saudita 8
IQ - Iraq 7
CL - Cile 6
EC - Ecuador 6
ET - Etiopia 6
MA - Marocco 6
UZ - Uzbekistan 6
BG - Bulgaria 5
EG - Egitto 5
IR - Iran 5
PT - Portogallo 5
UG - Uganda 5
AL - Albania 4
KE - Kenya 4
PE - Perù 4
TW - Taiwan 4
CR - Costa Rica 3
JM - Giamaica 3
KZ - Kazakistan 3
NO - Norvegia 3
OM - Oman 3
SC - Seychelles 3
TH - Thailandia 3
TJ - Tagikistan 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AM - Armenia 2
AZ - Azerbaigian 2
BO - Bolivia 2
BY - Bielorussia 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
IL - Israele 2
JO - Giordania 2
LB - Libano 2
LT - Lituania 2
MY - Malesia 2
NI - Nicaragua 2
NP - Nepal 2
PA - Panama 2
PK - Pakistan 2
PR - Porto Rico 2
PY - Paraguay 2
TN - Tunisia 2
AO - Angola 1
AW - Aruba 1
BB - Barbados 1
BN - Brunei Darussalam 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
DZ - Algeria 1
EE - Estonia 1
EU - Europa 1
HR - Croazia 1
IS - Islanda 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
LY - Libia 1
Totale 6.695
Città #
Frankfurt am Main 364
Ashburn 328
Singapore 303
Southend 263
Hong Kong 187
Milan 182
San Jose 161
Chandler 148
Dallas 115
Fairfield 105
Council Bluffs 94
Beijing 90
Los Angeles 83
Santa Clara 83
Seattle 71
New York 70
The Dalles 67
Wilmington 58
Ho Chi Minh City 55
Rome 54
Hefei 51
Dublin 46
Buffalo 43
Princeton 43
Jakarta 42
Woodbridge 39
Abidjan 38
Cambridge 37
Ann Arbor 36
Helsinki 34
Bengaluru 33
Guangzhou 33
Boardman 32
Houston 30
Hanoi 29
Lauterbourg 29
Phoenix 26
Toronto 26
Moscow 24
Munich 23
Shanghai 23
Naples 22
Redwood City 21
São Paulo 18
Turin 18
Dearborn 17
Columbus 16
Nanjing 16
Cangzhou 15
Seoul 15
Tokyo 15
Nuremberg 14
Margão 13
Da Nang 12
London 12
San Diego 12
Des Moines 11
Istanbul 11
Segrate 11
Atlanta 10
Dong Ket 10
Fuzhou 10
Montreal 10
San Valentino Torio 10
Shenzhen 10
Medellín 9
Brooklyn 8
Mumbai 8
Nanchang 8
Vienna 8
Brussels 7
Changsha 7
Florence 7
Genoa 7
Jinan 7
Johannesburg 7
Kent 7
Lappeenranta 7
Ottawa 7
Paris 7
Shenyang 7
Zurich 7
Chicago 6
Hillsboro 6
Hyderabad 6
Jacksonville 6
Newark 6
Orem 6
Piscataway 6
Rio de Janeiro 6
Riyadh 6
St Petersburg 6
Turku 6
Washington 6
Wuhan 6
Addis Ababa 5
Amsterdam 5
Bexley 5
Biên Hòa 5
Boston 5
Totale 4.155
Nome #
Contribution of transgender sex workers to the complexity of the HIV-1 epidemic in the metropolitan area of Milan 503
Improvement of ALT decay kinetics by all-oral HCV treatment : role of NS5A inhibitors and differences with IFN-based regimens 364
Evaluation of virological response and resistance profile in HIV-1 infected patients starting a first-line integrase inhibitor-based regimen in clinical settings 329
SARS-CoV-2 mRNA vaccine BNT162b2 triggers a consistent cross-variant humoral and cellular response 285
Favorable therapeutic response with an antiretroviral salvage regimen in an HIV-1-positive subject infected with a CRF11-cpx virus 281
Impact of SARS-CoV-2 Omicron and Delta variants in patients requiring intensive care unit (ICU) admission for COVID-19, Northern Italy, December 2021 to January 2022 269
Optimal efficacy of interferon-free HCV retreatment after protease inhibitor failure in real life 266
Time and mode of epidemic hcv-2 subtypes spreading in Europe: Phylodynamics in Italy and Albania 263
Multiclass HCV resistance to direct-acting antiviral failure in real-life patients advocates for tailored second-line therapies 258
Switch to maraviroc with darunavir/r, both QD, in patients with suppressed HIV-1 was well tolerated but virologically inferior to standard antiretroviral therapy : 48-Week results of a randomized trial 250
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels 246
Off-label use of tocilizumab for the treatment of SARS-CoV-2 pneumonia in Milan, Italy 243
Dynamics of viral DNA shedding and culture viral DNA positivity in different clinical samples collected during the 2022 mpox outbreak in Lombardy, Italy 241
Geographical reconstruction of the SARS‐CoV‐2 outbreak in Lombardy (Italy) during the early phase 223
Anti-HBV treatment induces novel reverse transcriptase mutations with reflective effect on HBV S antigen 196
Concomitant diagnosis of sexually transmitted infections and human monkeypox in patients attending a sexual health clinic in Milan, Italy 192
Brief Report : Impact of the COVID-19 Pandemic on Virological Suppression in People Living With HIV Attending a Large Italian HIV Clinic 192
Evolution of transmitted HIV-1 drug resistance and viral subtypes circulation in Italy from 2006 to 2016 191
Viral bloodstream detection in mpox patients: An observational multicentric study 189
Tenofovir plasma trough concentrations in people with HIV treated with doravirine versus other antiretroviral regimens 186
A case of extremely prolonged viral shedding: Could cell cultures be a diagnostic tool to drive COVID-19 patient discharge? 177
Reduced neutralization of SARS-CoV-2 Omicron variant by BNT162b2 vaccinees’ sera: a preliminary evaluation 175
Relapse of Kaposi's Sarcoma and HHV-8 viremia in an HIV-infected patient switching from protease inhibitor to integrase inhibitor-based antiretroviral therapy 173
Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI 159
A perspective Italian study on HIV-1 resistance in naive patients for antiretroviral therapy 153
Impact of circulating resistance-associated mutations on HIV pre-exposure prophylaxis (PrEP) efficacy : Modeling from antiretroviral resistance cohort analysis (ARCA) national database 145
Two individuals with potential monkeypox virus reinfection 129
Immunological failure in an HIV élite controller: Possible role of indirect markers of inflammation and benefit of antiretroviral therapy 128
Impact of SARS-CoV-2 omicron BA.1 and delta AY.4.2 variants on the neutralization by sera of patients treated with different authorized monoclonal antibodies 127
Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient 125
Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome 114
Evaluation of HIV-1 drug resistance in newly diagnosed individuals in Italy over the period 2017-2023 86
Comparison of diagnostic performances of HDV-RNA quantification assays used in clinical practice: Results from a national quality control multicenter study 40
null 3
Totale 6.901
Categoria #
all - tutte 21.236
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 21.236


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022386 0 0 35 10 43 25 34 21 52 58 14 94
2022/2023532 62 63 46 46 32 82 11 37 63 16 45 29
2023/2024716 23 41 34 40 150 54 70 65 28 48 76 87
2024/20251.185 77 115 54 124 83 65 62 93 65 134 112 201
2025/20262.654 255 187 263 237 186 148 391 105 214 173 274 221
2026/2027311 151 146 14 0 0 0 0 0 0 0 0 0
Totale 6.901